论文部分内容阅读
目的:对盆腔炎应用左氧氟沙星治疗的疗效以及安全性的观察分析。方法:选取自2013年2月20日~2014年1月20日我院收治的盆腔炎患者158例,将其随机分为观察组和对照组,两组均采用甲硝唑联合不同的抗生素用药,观察组联合左氧氟沙星进行口服治疗,对照组联合头孢氨苄进行口服治疗,通过对比分析比较二者的临床疗效与用药安全性。结果:观察组的有效率为91.14%明显高与对照组有效率79.74%,具有统计学意义,P<0.05;观察组的无效率为8.86%明显低于对照组20.25%,具有统计学意义,P<0.05。而观察组的总不良反应率为11.39%,对照组的总不良反应率为24.05%,对照组明显高于观察组(P<0.05)。结论:左氧氟沙星治疗盆腔炎的疗效显著,安全性较高,显著提高患者的生活质量,值得在临床上大范围推广使用。
Objective: To observe and analyze the efficacy and safety of levofloxacin in the treatment of pelvic inflammatory disease. Methods: 158 cases of pelvic inflammatory disease admitted to our hospital from February 20, 2013 to January 20, 2014 were randomly divided into observation group and control group. Metronidazole combined with different antibiotics The treatment group and the observation group were treated with levofloxacin orally, and the control group was treated with cefalexin orally. The clinical efficacy and safety of the two drugs were compared by comparative analysis. Results: The effective rate of the observation group was 91.14%, which was significantly higher than that of the control group (79.74%), with statistical significance (P <0.05). The observation group had an effective rate of 8.86%, which was significantly lower than that of the control group (20.25% P <0.05. The total adverse reaction rate was 11.39% in the observation group and 24.05% in the control group, which was significantly higher in the control group than in the observation group (P <0.05). Conclusion: The levofloxacin treatment of pelvic inflammatory disease significant effect, higher safety, significantly improve the quality of life of patients, it is worth in the clinical application of a wide range.